Treatment Set TS333312 (Antigen Laboratories, Inc.)
Welcome to the PulseAid listing for the Treatment Set TS333312 drug offered from Antigen Laboratories, Inc.. This Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Antigen Laboratories, Inc. |
NON-PROPRIETARY NAME: | Treatment Set TS333312 |
SUBSTANCE NAME: | ALTERNARIA ALTERNATA; ACER NEGUNDO POLLEN; PLATANUS OCCIDENTALIS POLLEN; FRAXINUS AMERICANA POLLEN; CYNODON DACTYLON POLLEN; PHLEUM PRATENSE POLLEN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
ROUTE: | INTRADERMAL; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-12-18 |
END MARKETING DATE: | 0000-00-00 |
Treatment Set TS333312 HUMAN PRESCRIPTION DRUG Details:
Item Description | Treatment Set TS333312 from Antigen Laboratories, Inc. |
LABELER NAME: | Antigen Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .002; .01; .01; .01; 80; 800(g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL) |
START MARKETING DATE: | 2009-12-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49288-0667_89f9e682-acd9-4cc7-982d-c32f69b33b07 |
PRODUCT NDC: | 49288-0667 |
APPLICATION NUMBER: | BLA102223 |
Other ALTERNARIA ALTERNATA; ACER NEGUNDO POLLEN; PLATANUS OCCIDENTALIS POLLEN; FRAXINUS AMERICANA POLLEN; CYNODON DACTYLON POLLEN; PHLEUM PRATENSE POLLEN Pharmaceutical Manufacturers / Labelers: